Theralase Technologies Inc (TLT) - Product Pipeline Analysis, 2019 Update

Summary

Theralase Technologies Inc (Theralase) is a clinical stage pharmaceutical company which specializes in design, development, and manufacturing of laser based technologies used in wide range of bio-destructive and bio-simulative clinical applications. The company is focused on the development of laser-based non-invasive therapeutic devices (laser systems) used for the reduction of inflammation, chronic knee pain, and accelerate tissue healing for numerous nerve, muscle, and joint conditions. Theralases photo dynamic therapy is dedicated on the discovery and development of small, light-activated photo dynamic compounds (PDCs) and their associated drug formulations based on its proprietary non-immunosuppressive photodynamic technology targeting cancer cells, bacterial infections, and promote microbial sterilization. The company markets its products through a network of distributors in Canada, the US and internationally. Theralase Technologies is headquartered in Toronto, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Theralase Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company


List of Tables
List of Figures
Theralase Technologies Inc Company Overview
Theralase Technologies Inc Company Snapshot
Theralase Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
Theralase Technologies Inc Pipeline Analysis Overview
Theralase Technologies Inc - Key Facts
Theralase Technologies Inc - Major Products and Services
Theralase Technologies Inc Pipeline Products by Development Stage
Theralase Technologies Inc Ongoing Clinical Trials by Trial Status
Theralase Technologies Inc Pipeline Products Overview
TLC-3000 Photo Dynamic Therapy Laser System
TLC-3000 Photo Dynamic Therapy Laser System Product Overview
TLC-3000 Photo Dynamic Therapy Laser System Clinical Trial
TLC-3200 Medical Laser
TLC-3200 Medical Laser Product Overview
TLC-3200 Medical Laser Clinical Trial
TLC-3400 Medical Laser
TLC-3400 Medical Laser Product Overview
Theralase Technologies Inc - Key Competitors
Theralase Technologies Inc - Key Employees
Theralase Technologies Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Theralase Technologies Inc, Recent Developments
May 30, 2019: Theralase releases 1Q 2019 financial statements
May 07, 2019: Chinese Patent Office Issues Notice of acceptance for multiwavelength photodynamic therapy
Feb 25, 2019: Theralase announces appointment of new chief executive officers
Dec 10, 2018: Health Canada grants ITA approval to commence phase II clinical study
Nov 29, 2018: Theralase release 3Q 2018 financial statements
Sep 10, 2018: Health Canada approves commencement of phase II clinical study
Jul 26, 2018: Theralase Released 2Q2018 Financial Statements
Jun 28, 2018: Theralase Researchers Receive Government Grant
Jun 22, 2018: Theralase Strengthens Its Patent Portfolio with an Additional US Patent Covering Metal-Glycoprotein Complexes, Including Rutherrin(R) Based Photo Dynamic Therapy, in Immune Privileged Sites
May 30, 2018: Theralase Increases Revenue 22% for 2017 Financial Statements
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

List of Tables
Theralase Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
Theralase Technologies Inc Pipeline Products by Equipment Type
Theralase Technologies Inc Pipeline Products by Indication
Theralase Technologies Inc Ongoing Clinical Trials by Trial Status
Theralase Technologies Inc, Key Facts
Theralase Technologies Inc, Major Products and Services
Theralase Technologies Inc Number of Pipeline Products by Development Stage
Theralase Technologies Inc Pipeline Products Summary by Development Stage
Theralase Technologies Inc Ongoing Clinical Trials by Trial Status
Theralase Technologies Inc Ongoing Clinical Trials Summary
TLC-3000 Photo Dynamic Therapy Laser System - Product Status
TLC-3000 Photo Dynamic Therapy Laser System - Product Description
TLC-3000 Photo Dynamic Therapy Laser System - A Phase II Clinical Study of Intravesical Photodynamic Therapy in Patients with BCG-Unresponsive Non-muscle Invasive Bladder Cancer ("NMIBC") or Patients who Are Intolerant to BCG Therapy ("Study")
TLC-3200 Medical Laser - Product Status
TLC-3200 Medical Laser - Product Description
TLC-3200 Medical Laser - A Phase II Clinical Study of Intravesical Photodynamic Therapy in Patients with BCG-Unresponsive Non-muscle Invasive Bladder Cancer ("NMIBC") or Patients who Are Intolerant to BCG Therapy ("Study")
TLC-3400 Medical Laser - Product Status
TLC-3400 Medical Laser - Product Description
Theralase Technologies Inc, Key Employees
Theralase Technologies Inc, Subsidiaries
Glossary

List Of Figures

List of Figures
Theralase Technologies Inc Pipeline Products by Equipment Type
Theralase Technologies Inc Pipeline Products by Development Stage
Theralase Technologies Inc Ongoing Clinical Trials by Trial Status

Theralase Technologies Inc (TLT) - Product Pipeline Analysis, 2017 Update

Theralase Technologies Inc (Theralase) is a medical equipment company that designs, develops and manufactures laser and laser technology for human, companion animal and equine applications. The company offers products such

USD 750 View Report

Theralase Technologies Inc (TLT) - Medical Equipment - Deals and Alliances Profile.

Theralase Technologies Inc (TTI) is a medical equipment company that designs, develops and manufactures laser and laser technology for human, companion animal and equine applications. The company provides products such

USD 250 View Report

Mind Technologies Inc (MIND) - Financial and Strategic SWOT Analysis Review

MIND Technologies Inc (MIND) is a diversified company. The company designs, manufactures and markets marine sonar and seismic equipment, exploration equipment and specialized equipment. It offers seismic source acquisition and

USD 300 View Report

Theralink Technologies Inc (OBMP) - Financial and Strategic SWOT Analysis Review

Theralink Technologies Inc (Theralink), formerly OncBioMune Pharmaceuticals Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The companys products comprise biosimilars and vaccines developed for cancer types such

USD 300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available